Hemorrhage Risk Among Patients With Breast Cancer Receiving Concurrent Direct Oral Anticoagulants With Tamoxifen vs Aromatase Inhibitors

Practical treatment guidance for cancer-associated thrombosis – Managing the challenging patient: A consensus statement

(2022) Kathryn M. Musgrave et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

(2021) Gary H. Lyman et al.   Blood Advances

Risk of major bleeding associated with concomitant use of anticancer drugs and direct oral anticoagulant in patients with cancer and atrial fibrillation

(2021) Chun-Li Wang et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Overlap Weighting

(2020) Laine E. Thomas et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

(2020) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rates of Potentially Inappropriate Dosing of Direct‐Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE‐AF Study

(2020) Saket Sanghai et al.   Journal of the American Heart Association

Direct oral anticoagulants in the prevention of stroke in breast cancer patients with atrial fibrillation during adjuvant endocrine therapy: A cohort study

(2020) Renata Pacholczak-Madej et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Venous thromboembolism in cancer patients: a population-based cohort study

(2020) F. I. Mulder et al.   BLOOD

Incidence of atrial fibrillation in conjunction with breast cancer

(2019) Maria D’Souza et al.   HEART RHYTHM

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

(2019) Nigel S. Key et al.   JOURNAL OF CLINICAL ONCOLOGY

Incidence of atrial fibrillation in different major cancer subtypes: a Nationwide population-based 12 year follow up study

(2019) Christina Boegh Jakobsen et al.   BMC CANCER

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

(2018) Gary E. Raskob et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anticancer Drug-Related Nonvalvular Atrial Fibrillation: Challenges in Management and Antithrombotic Strategies

(2018) Maurizio Galderisi et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients’ Quality of Life?

(2018) Andrew J. Lloyd et al.   VALUE IN HEALTH

How I treat cancer-associated venous thromboembolism

(2018) Noémie Kraaijpoel et al.   BLOOD

Balancing Covariates via Propensity Score Weighting

(2017) Fan Li et al.   JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION

Epidemiology of first and recurrent venous thromboembolism in patients with active cancer

(2017) Anja Katholing et al.   THROMBOSIS AND HAEMOSTASIS

Drug-drug interactions of non-vitamin K oral anticoagulants

(2016) Christos Voukalis et al.   Expert Opinion on Drug Metabolism & Toxicology

The Risk of Major Hemorrhage with CKD

(2016) A. O. Molnar et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data

(2015) A. J. Walker et al.   BLOOD

Why do we need observational studies of everyday patients in the real-life setting?: Table 1

(2015) Alexander T. Cohen et al.   EUROPEAN HEART JOURNAL SUPPLEMENTS

New Oral Anticoagulants and the Cancer Patient

(2013) N. J. Short et al.   ONCOLOGIST

Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research

(2009) Peter C. Austin   COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION